Tariff Talk: Navigating Reciprocal Trade Laws

Tariff Talk: Navigating Reciprocal Trade Laws

Understanding Reciprocal Tariffs Reciprocal tariffs are structured in a way that corresponds directly with the tariffs imposed by other countries on U.S. goods. Unlike standard tariffs, which typically arise from established agreements among countries—such as those...

read more
FDAImports Presents at Seafood Expo North America 

FDAImports Presents at Seafood Expo North America 

FDAImports is excited to participate in the 2025 Seafood Expo North America in Boston, March 16th-18th.   Ben England, our Founder and CEO, is going to speak on “Customs and FDA Enforcement: Challenges for Imports in 2025.” Ben’s presentation is March 16th, 2025,...

read more
FDA Detentions Unpacked: Navigating Import Regulations

FDA Detentions Unpacked: Navigating Import Regulations

Shifts in FDA and Customs Regulations Under Changing Administrations As we see new leadership in Washington, there’s no shortage of questions surrounding customs and FDA regulations for imported goods. The back-and-forth between administrations can often bring about...

read more
FDA-Regulated Products in Importation

FDA-Regulated Products in Importation

The U.S. Food and Drug Administration (FDA) plays a crucial role in regulating a significant portion of imports, overseeing about 40% of the U.S. GDP. FDA regulations impact various product categories, including: Food Products: FDA regulates most food products,...

read more
FDA 2025 Registration Renewal Season Opens October 1, 2024

FDA 2025 Registration Renewal Season Opens October 1, 2024

Between October 1 and December 31, Food and Drug Administration (FDA)-registered facilities must renew their registrations. Our team has handled registration renewals for thousands of facilities. Here are some things you need to know to ensure your renewal is...

read more
FDA Updates Drug Reporting Requirements

FDA Updates Drug Reporting Requirements

On February 5, 2024, FDA issued a final guidance regarding reporting by drug establishments for listed drug and biological products manufactured, prepared, propagated, compounded, or processed for commercial distribution. The upshot is that drugs listed with FDA must...

read more
New FDA Draft Guidance Impacts Seafood Importers and Processors

New FDA Draft Guidance Impacts Seafood Importers and Processors

On February 9, 2024, FDA issued “Recommendations for Collecting Representative Samples for Food Testing Used as Evidence for Release of Certain Fish and Fishery Products Subject to Detention Without Physical Examination (DWPE) and Removal of a Foreign Manufacturer’s...

read more